Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3440877rdf:typepubmed:Citationlld:pubmed
pubmed-article:3440877lifeskim:mentionsumls-concept:C0349604lld:lifeskim
pubmed-article:3440877lifeskim:mentionsumls-concept:C0242349lld:lifeskim
pubmed-article:3440877pubmed:issue4lld:pubmed
pubmed-article:3440877pubmed:dateCreated1988-4-13lld:pubmed
pubmed-article:3440877pubmed:abstractTextFifty meningiomas of four major histological types have been examined by immunocytochemical methods applied to formalin fixed paraffin embedded material and using readily available commercial antisera. The expression of GFAP, S100, NSE, vimentin, cytokeratin, fibronectin and desmoplakin was investigated. The majority of tumours contained NSE (86%) and S100 (78%), and all irrespective of histological type, contained vimentin and fibronectin. The epithelial marker cytokeratin was found in 56% of cases, but showed only focal expression. The relevance of these findings to histogenesis and metabolism is discussed and it is suggested that intermediate filament typing provides valuable information on meningiomas structure and function. The possible role of NSE and S100 in meningeal neoplasm is discussed.lld:pubmed
pubmed-article:3440877pubmed:languageenglld:pubmed
pubmed-article:3440877pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3440877pubmed:citationSubsetIMlld:pubmed
pubmed-article:3440877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3440877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3440877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3440877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3440877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3440877pubmed:statusMEDLINElld:pubmed
pubmed-article:3440877pubmed:issn0167-594Xlld:pubmed
pubmed-article:3440877pubmed:authorpubmed-author:MorrisC SCSlld:pubmed
pubmed-article:3440877pubmed:authorpubmed-author:HitchcockEElld:pubmed
pubmed-article:3440877pubmed:issnTypePrintlld:pubmed
pubmed-article:3440877pubmed:volume5lld:pubmed
pubmed-article:3440877pubmed:ownerNLMlld:pubmed
pubmed-article:3440877pubmed:authorsCompleteYlld:pubmed
pubmed-article:3440877pubmed:pagination357-68lld:pubmed
pubmed-article:3440877pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:meshHeadingpubmed-meshheading:3440877-...lld:pubmed
pubmed-article:3440877pubmed:year1987lld:pubmed
pubmed-article:3440877pubmed:articleTitleImmunocytochemistry of intracranial meningiomas.lld:pubmed
pubmed-article:3440877pubmed:affiliationDepartment of Neurosurgery, University of Birmingham, Canada.lld:pubmed
pubmed-article:3440877pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3440877pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed